Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Acinar Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04543071
What this trial is testing

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasAdenocarcinoma
Columbia University 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207944
What this trial is testing

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Who this might be right for
IPMNIPMN, Pancreatic
Duke University 100
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Not applicableStudy completedNCT06363084
What this trial is testing

A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Ruijin Hospital 64
Not applicableStudy completedNCT02920944
What this trial is testing

Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions

Who this might be right for
Pancreatic Neoplasms
Seung Bae Yoon 35
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Not applicableStudy completedNCT01727921
What this trial is testing

Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic Mass

Who this might be right for
Pancreatic Neoplasms
Samsung Medical Center 219
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Testing effectiveness (Phase 2)Looking for participantsNCT04858334
What this trial is testing

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Adenosquamous CarcinomaPancreatic Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 152
Not applicableLooking for participantsNCT06148298
What this trial is testing

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Who this might be right for
Cancer of Pancreas
University of Central Florida 24
Testing effectiveness (Phase 2)Ended earlyNCT02202785
What this trial is testing

MLN0264 in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Millennium Pharmaceuticals, Inc. 43
Testing effectiveness (Phase 2)UnknownNCT05298020
What this trial is testing

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University 20
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Temporarily pausedNCT07173374
What this trial is testing

Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic Cancer
Shandong Cancer Hospital and Institute 24
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Not applicableStudy completedNCT03788382
What this trial is testing

Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer

Who this might be right for
Pancreatic Malignant Neoplasm Primary
Universita di Verona 317
Not applicableUnknownNCT03951324
What this trial is testing

Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study

Who this might be right for
Biliary StricturePancreas CancerCholangiocarcinoma+14 more
Innovative Digestive Health Education and Research Inc 40
Testing effectiveness (Phase 2)Study completedNCT02210559
What this trial is testing

Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer (Unresectable)
Kyntra Bio 37
Early research (Phase 1)Ended earlyNCT03825289
What this trial is testing

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CarcinomaStage II Pancreatic CancerStage IIA Pancreatic Cancer+4 more
University of Utah 25
Next Page